Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Elevated serum β2-glycoprotein-I-lipoprotein(a) complexes levels are associated with the presence and complications in type 2 diabetes mellitus.

Wang C, Niu DM, Hu J, Guan XC, Yang W, Wang JJ, Zhang CY, Zhang CN.

Diabetes Res Clin Pract. 2013 May;100(2):250-6. doi: 10.1016/j.diabres.2013.03.002. Epub 2013 Mar 30.

PMID:
23549246
2.

Increased serum levels of β₂-GPI-Lp(a) complexes and their association with premature atherosclerosis in patients with rheumatoid arthritis.

Zhang C, Li X, Niu D, Zi R, Wang C, Han A, Wang X, Li K, Wang J.

Clin Chim Acta. 2011 Jul 15;412(15-16):1332-6. doi: 10.1016/j.cca.2011.03.029. Epub 2011 Apr 5.

PMID:
21473861
3.

Elevated serum β₂-GPI-Lp(a) complexes levels in children with nephrotic syndrome.

Zhang C, Luo Y, Huang Z, Xia Z, Cai X, Yang Y, Niu D, Wang J.

Clin Chim Acta. 2012 Oct 9;413(19-20):1657-60. doi: 10.1016/j.cca.2012.05.006. Epub 2012 May 15.

PMID:
22609258
4.

Elevated beta2-glycoprotein I-low-density lipoprotein levels are associated with the presence of diabetic microvascular complications.

Yu R, Yuan Y, Niu D, Song J, Liu T, Wu J, Wang J.

J Diabetes Complications. 2015 Jan-Feb;29(1):59-63. doi: 10.1016/j.jdiacomp.2014.09.010. Epub 2014 Sep 28.

PMID:
25449980
5.

Lipoprotein(a) complexes with beta2-glycoprotein I in patients with coronary artery disease.

Wang JJ, Gong JB, Li HQ, Niu DM, Han AZ, Wu J, Zhang CN.

J Atheroscler Thromb. 2012;19(1):81-9. Epub 2011 Nov 7.

6.

Serum lipoprotein(a) complexes with beta2-glycoprotein I levels in patients with ischemic stroke.

Ma L, Wu J, Niu D, Yu R, Song J, Zhang C, Wang J.

Clin Chim Acta. 2014 Feb 15;429:163-7. doi: 10.1016/j.cca.2013.11.029. Epub 2013 Dec 4.

PMID:
24315780
7.

Detection of serum beta(2)-GPI-Lp(a) complexes in patients with systemic lupus erythematosus.

Zhang C, Li K, Shi B, Wang X, Liu X, Qin W, Han A, Wang J.

Clin Chim Acta. 2010 Mar;411(5-6):395-9. doi: 10.1016/j.cca.2009.12.008. Epub 2009 Dec 21.

PMID:
20026018
8.
9.

Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.

Lopez LR, Hurley BL, Simpson DF, Matsuura E.

Ann N Y Acad Sci. 2005 Jun;1051:97-103.

PMID:
16126948
10.
11.

Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes.

Heesen BJ, Wolffenbuttel BH, Leurs PB, Sels JP, Menheere PP, Jäckle-Beckers SE, Nieuwenhuijzen Kruseman AC.

Eur J Clin Invest. 1993 Sep;23(9):580-4.

PMID:
8243530
12.

Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.

Murase T, Okubo M, Amemiya-Kudo M, Ebara T, Mori Y.

Metabolism. 2008 Jun;57(6):791-5. doi: 10.1016/j.metabol.2008.01.020.

PMID:
18502261
13.

Fibronectin and lipoprotein(a) are inversely related to plasminogen activator inhibitor type-1 levels in Type 2 diabetic patients without complications.

Testa R, Bonfigli AR, Sirolla C, De Grazia G, Compagnucci P, Manfrini S, Fumelli D, Testa I.

Diabetes Nutr Metab. 2000 Oct;13(5):269-75.

PMID:
11105969
14.

Evaluation of serum glycated lipoprotein(a) levels in noninsulin-dependent diabetic patients.

Klaya F, Durlach V, Bertin E, Monier F, Monboisse JC, Gillery P.

Clin Biochem. 1997 Apr;30(3):227-30.

PMID:
9167899
15.

Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.

Murase T, Okubo M, Amemiya-Kudo M, Hiraga T, Oka J, Shimada M, Igarashi T.

Metabolism. 2007 Sep;56(9):1187-91.

PMID:
17697860
16.

Autoantibodies to the atheroma component beta2-glycoprotein I and risk of symptomatic peripheral artery disease.

Franck M, Staub HL, Petracco JB, Norman GL, Lassen AJ, Schiavo N, Borges RB, von Mühlen CA.

Angiology. 2007 Jun-Jul;58(3):295-302.

PMID:
17626983
17.

Study of antiphospholipid antibodies in type 2 diabetes mellitus with and without diabetic retinopathy.

Cojocaru IM, Cojocaru M, Popescu AN, Popescu L, Tănăsescu R.

Rom J Intern Med. 2009;47(3):267-71.

PMID:
20446442
18.

Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus.

Gazzaruso C, Coppola A, Montalcini T, Baffero E, Garzaniti A, Pelissero G, Collaviti S, Grugnetti A, Gallotti P, Pujia A, Solerte SB, Giustina A.

Endocrine. 2012 Feb;41(1):89-95. doi: 10.1007/s12020-011-9544-4. Epub 2011 Oct 11.

PMID:
21986921
20.

Anticardiolipin and anti-beta2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus.

Tarkun I, Hacihanefioğlu A, Tarkun P, Cetinarslan B, Cantürk Z.

Diabetes Res Clin Pract. 2005 Jun;68(3):181-7.

PMID:
15936458

Supplemental Content

Support Center